Skip to main content
Caplight Logo









E-Leviate Pharma

E-Leviate Pharma

Private
AucklandHealthcare & Life Scienceshttps://www.e-leviate.com/

Last Round

Seed

Dec 18, 2025

Total Funding Raised

$500,000

Company Overview

E-Leviate Pharma is a therapeutic devices company that develops a novel drug-device for a range of common gynecological conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

women's healthestriol-eluting pessarypelvic organ prolapsePOPdrug-device combinationdrug-eluting devicevaginal pessaryfemtechdrug deliveryhormone therapygenitourinary syndrome of menopauseGSMvaginal atrophymedtechclinical-stage company

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

E-Leviate Pharma Comparables

Compare E-Leviate Pharma with similar companies based on industry and business-model similarity.

E-Leviate Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FemTherapeutics
83%
Reia
80%
Epigenuity LLC
77%

E-Leviate Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 18, 2025

Key People

Founding team and executive leadership

Prathima Chowdary

Chief Executive Officer

Executive Team

E-Leviate Pharma Investors

Notable investors and investment history

E-Leviate Pharma investors
InvestorRounds
Icehouse VenturesSeed
SOUL CapitalSeed
Outset VenturesPre Seed, Seed
Nuance Connected CapitalSeed
Clare VenturesPre Seed, Seed

E-Leviate Pharma Filings

Explore SEC and related filing metadata, where available.

E-Leviate Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about E-Leviate Pharma's valuation, stock price, and market status.

Is E-Leviate Pharma a public or private company?

E-Leviate Pharma is a private company.

What is the current stock price of E-Leviate Pharma?

E-Leviate Pharma is a private company with no public stock price. No recent secondary market data is available.

How much is E-Leviate Pharma worth (valuation)?

Valuation information for E-Leviate Pharma is not publicly available.

Can I buy E-Leviate Pharma stock?

E-Leviate Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was E-Leviate Pharma's last funding round?

Funding round information for E-Leviate Pharma is not publicly available.

Who are the main investors in E-Leviate Pharma?

Investor information for E-Leviate Pharma is not publicly disclosed.

Will E-Leviate Pharma IPO soon?

No public IPO plans have been announced for E-Leviate Pharma.

How can I track E-Leviate Pharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor E-Leviate Pharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAuckland
Employee Range5
Year Founded2023
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?